We are live on ! Find out more
BDTX icon

Black Diamond Therapeutics
BDTX

80 hedge funds and large institutions have $968M invested in Black Diamond Therapeutics in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 4

123% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 13

74% more capital invested

Capital invested by funds: $556M → $968M (+$412M)

23% more funds holding

Funds holding: 65 → 80 (+15)

2.34% more ownership

Funds ownership: 62.09% → 64.43% (+2.3%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
80
Holders Change
+15
Holders Change %
+23.08%
% of All Funds
1.64%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
20
Increased
29
Reduced
13
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$9.8M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.45M
3
BlackRock
BlackRock
New York
+$6.8M
4
IC
Ikarian Capital
Texas
+$6.53M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.36M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$6M
2
AG
Artal Group
Luxembourg
-$5.52M
3
VC
Vivo Capital
California
-$3.75M
4
Goldman Sachs
Goldman Sachs
New York
-$2.69M
5
JP Morgan Chase
JP Morgan Chase
New York
-$982K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$5.54M +$325K +8,839 +7%
EA
27
Emerald Advisers
Pennsylvania
$4.93M +$90.5K +2,460 +2%
LGM
28
Logos Global Management
California
$4.68M – – –
EMFAT
29
Emerald Mutual Fund Advisers Trust
Pennsylvania
$4.51M -$133K -3,601 -3%
Norges Bank
30
Norges Bank
Norway
$4.22M – – –
Charles Schwab
31
Charles Schwab
California
$3.43M +$2.05M +55,702 +218%
JP Morgan Chase
32
JP Morgan Chase
New York
$3.11M -$982K -26,689 -27%
ACH
33
ArrowMark Colorado Holdings
Colorado
$2.95M – – –
ACM
34
Atika Capital Management
New York
$2.95M -$925K -25,126 -26%
N
35
Nuveen
North Carolina
$2.07M +$480K +13,047 +36%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.96M +$592K +16,082 +53%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$1.15M +$1M +27,224 New
Renaissance Technologies
38
Renaissance Technologies
New York
$1.12M +$976K +26,507 New
FAM
39
Fred Alger Management
New York
$1.01M +$258K +7,000 +41%
BFM
40
Boothbay Fund Management
New York
$929K +$811K +22,028 New
Alyeska Investment Group
41
Alyeska Investment Group
Illinois
$910K +$795K +21,591 New
Prudential Financial
42
Prudential Financial
New Jersey
$883K +$1.84K +50 +0.2%
Allianz Asset Management
43
Allianz Asset Management
Germany
$871K -$185K -5,033 -20%
Swiss National Bank
44
Swiss National Bank
Switzerland
$843K +$736K +20,000 New
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$784K – – –
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$773K – – –
AC
47
Athanor Capital
New York
$750K +$655K +17,796 New
Goldman Sachs
48
Goldman Sachs
New York
$718K -$2.69M -73,020 -81%
Deutsche Bank
49
Deutsche Bank
Germany
$661K +$75.3K +2,045 +15%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$638K +$113K +3,079 +26%
1
2
3 4

BDTX Hedge Fund Activity: Q2 2020 in Review

80 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Black Diamond Therapeutics (BDTX) for Q2 2020, worth a combined $968M — up 74% from $556M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new BDTX positions and 4 closed out — a net gain of 16 holders — while 29 added to existing stakes and 13 trimmed.

The largest buyer was Wells Fargo, adding an estimated $9.8M. The largest seller was Fidelity Investments, cutting an estimated $6M.

  • 80 institutional investors held Black Diamond Therapeutics (BDTX) as of Q2 2020, up from 65 in Q1 2020.
  • Funds reported $968M of Black Diamond Therapeutics stock for Q2 2020, up 74% quarter-over-quarter.
  • 20 funds opened new Black Diamond Therapeutics positions in Q2 2020 and 4 closed out, a net change of +16 holders.
  • The largest Black Diamond Therapeutics buyer in Q2 2020 was Wells Fargo, an estimated $9.8M added.
  • The largest Black Diamond Therapeutics seller in Q2 2020 was Fidelity Investments, an estimated $6M sold.

Based on aggregated 13F filings for Q2 2020.